000			01968 a2200529 4500
005			20250515175203.0
264		0	_c20101021
008			201010s 0 0 eng d
022			_a1573-0646
024	7		_a10.1007/s10637-009-9281-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aBrüning, Ansgar
245	0	0	_aNelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib. _h[electronic resource]
260			_bInvestigational new drugs _cOct 2010
300			_a535-42 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnnexin A5 _xmetabolism
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBenzenesulfonates _xpharmacology
650	0	4	_aCell Death _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Synergism
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xmetabolism
650	0	4	_aFemale
650	0	4	_aHIV Protease Inhibitors _xpharmacology
650	0	4	_aHumans
650	0	4	_aMembrane Potential, Mitochondrial _xdrug effects
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aMyeloid Cell Leukemia Sequence 1 Protein
650	0	4	_aNelfinavir _xpharmacology
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aOvarian Neoplasms _xenzymology
650	0	4	_aPhenylurea Compounds
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPropidium _xmetabolism
650	0	4	_aProtein Stability _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xmetabolism
650	0	4	_aPyridines _xpharmacology
650	0	4	_aSorafenib
700	1		_aBurger, Petra
700	1		_aVogel, Marianne
700	1		_aGingelmaier, Andrea
700	1		_aFriese, Klaus
700	1		_aBurges, Alexander
773	0		_tInvestigational new drugs _gvol. 28 _gno. 5 _gp. 535-42
856	4	0	_uhttps://doi.org/10.1007/s10637-009-9281-1 _zAvailable from publisher's website
999			_c18971760 _d18971760